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Cardiovascular disease is the leading cause of
death in developed and developing countries. In Asia,
heart attacks and stroke are major causes of morbidity
and  mor ta l i ty.  The  r i sk  fac tors  l ead ing  to
cardiovascular disease are well known.1 Of these,
smoking, blood pressure and cholesterol are the
major modifiable risk factors. In highly developed
countries such as the United States, we and others
have shown that the prevalence of these risk factors
is declining.2 This is not the case in developing
countries.
Cardiovascular diseases form a continuum,3 in
which  ca rd iovascu la r  r i sk  fac to r s  l ead  to
atherosclerosis, which is not clinically overt at first,
but in middle age, may manifest itself as ischaemic
heart disease, cerebrovascular and peripheral
vascular disease. In old age, accumulated injuries to
the myocardium lead to chronic heart failure whereas
in the brain, vascular disease is an important cause
of senile dementia. The question then arises − can
we intervene earlier in the cardiovascular continuum?
Data from the Hong Kong Cardiovascular Risk
Factor Prevalence Study showed that hypertension
and diabetes are sequelae of obesity.4,5 They support
the usefulness of the concept of the metabolic
syndrome.6-8 Central obesity leads to elevated
triglycerides and reduced high density lipoprotein
cholesterol. Raised blood pressure and raised blood
glucose follow later.9,10 This provides a window of
opportunity to prevent cardiovascular disease by
preventing the development of the leading risk
factors. Numerous studies have shown that lifestyle
measures to reduce central obesity will reduce blood
pressure and the development of diabetes.11-13
As a result of economical development,
physical activity is declining in Asia.14,15 HDL does
not decrease with age in American women but it does
so in Hong Kong Chinese women.16 At the same time,
a diet that traditionally provides abundant calories
for farming and manual labour may be inappropriate
for a sedentary lifestyle.17-19 This may explain the high
incidence of diabetes among Asians.
For those who already have cardiovascular
disease, medications to modify blood pressure,
cholesterol and platelet function have been shown
in large cl inical  tr ials  and meta-analyses to
have favourable effects on outcome.20-23 The
INTERHEART study has eloquently shown that 90%
of heart attacks can be explained by nine risk factors,
the majority of which are related to lifestyle and can
be modified by changes in lifestyle.24 It is high time
we put this knowledge into action.
References
1. Kannel WB, McGee D, Gordon T. A general cardiovascular
risk profile: the Framingham Study. Am J Cardiol 1976; 38:
46-51.
2. Ong KL, Cheung BM, Man YB, et al. Prevalence, awareness,
treatment and control of hypertension among United States
adults 1999-2004. Hypertension 2007;49:69-75.
3. Cheung BM. The cardiovascular continuum in Asia - a new
paradigm for the metabolic syndrome. J Cardiovasc Pharmacol
2005;46:125-9.
4. Cheung BM, Wat NM, Man YB, et al. Relationship Between
the Metabolic Syndrome and the Development of Hypertension
in the Hong Kong Cardiovascular Risk Factor Prevalence Study-
2 (CRISPS2). Am J Hypertens 2008;21:17-22.
KOHZUKI ET AT.
November 2008J HK Coll Cardiol, Vol 16 (Suppl 1) A49
5. Cheung BM, Wat NM, Man YB, et al. Development of diabetes
in Chinese with the metabolic syndrome - a six year prospective
study. Diabetes Care 2007;30:1430-6.
6. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and
management of the metabolic syndrome: an American Heart
Association/National Heart, Lung, and Blood Institute Scientific
Statement. Circulation 2005;112:2735-52.
7. Alberti KG, Zimmet P, Shaw J, et al. The metabolic syndrome
--a new worldwide definition. Lancet 2005;366:1059-62.
8. Cheung BM, Wat NM, Tam S, et al. Components of the
Metabolic Syndrome Predictive of its Development: A Six Year
Longitudinal Study in Hong Kong Chinese. Clin Endocrinol
2008;68:730-7.
9. Cheung BM. Hypertension as part of the metabolic syndrome.
J Hum Hypertens 2008 Jun 12. [Epub ahead of print]
10. Cheung BM, Li MF, Ong KL, et al. Raised blood pressure and
dysglycemia in Hong Kong Chinese. Diabetes Care 2008;31:
1889-91.
11. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in
preventing NIDDM in people with impaired glucose tolerance.
The Da Qing IGT and Diabetes Study. Diabetes Care 1997;20:
537-44.
12. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of
type 2 diabetes mellitus by changes in lifestyle among subjects
with impaired glucose tolerance. N Engl J Med 2001;344:1343-
50.
13. Lien LF, Brown AJ, Ard JD, et al. Effects of PREMIER lifestyle
modifications on participants with and without the metabolic
syndrome. Hypertension 2007;50:609-16.
14. Lam TH, Ho SY, Hedley AJ, et al. Leisure time physical activity
and mortality in Hong Kong: case-control study of all adult
deaths in 1998. Ann Epidemiol 2004;14:391-8.
15. Cheung BM, Thomas GN. The metabolic syndrome and
vascular disease in Asia. Cardiovasc Hematol Disord Drug
Targets 2007;7:79-85.
16. Cheung BM, Li M, Ong KL, et al. High Density Lipoprotein-
Cholesterol Levels Increase with Age in American Women but
not in Hong Kong Chinese Women. Clin Endocrinol 2008.
Accepted.
17. Woo J, Cheung B, Ho SC, et al. Influence of dietary pattern on
the development of overweight and obesity in a Chinese
population. Eur J Clin Nutr 2008;62:480-7.
18. Schooling CM, Ho SY, Leung GM, et al. Diet synergies and
mortality--a population-based case-control study of 32,462 Hong
Kong Chinese older adults. Int J Epidemiol 2006;35:418-26.
19. Thomas GN, Cheung BM, Ho SY, et al. Overview of dietary
influences on atherosclerotic vascular disease: epidemiology
and prevention. Cardiovasc Hematol Disord Drug Targets 2007;
7:87-97.
20. Lewington S, Clarke R, Qizilbash N, et al. Age-specific
relevance of usual blood pressure to vascular mortality: a meta-
analysis of individual data for one million adults in 61
prospective studies. Lancet 2002;360:1903-13.
21. Cheung BM, Lauder IJ, CP Lau, et al. Meta-analysis of large
randomised controlled trials to evaluate the impact of statins
on cardiovascular outcomes. Brit J Clin Pharmacol 2004;57:
640-51.
22. Cheung BM. Statins for people with diabetes. Lancet 2008;
371:94-5.
23. Kumana CR, Cheung G, Lauder IJ, et al. Long-term
combination therapy with aspirin and clopidogrel. J Cardiovasc
Pharmacol Thera 2004;9:223-5.
24. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially
modifiable risk factors associated with myocardial infarction
in 52 countries (the INTERHEART study): case-control study.
Lancet 2004;364:937-52.
